NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/30/2019
Back to search
Official data from USPTO
AMERICAN SOCIETY FOR EXPERIMENTAL NEUROTHERAPEUTICS ASENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
AMERICAN SOCIETY FOR EXPERIMENTAL NEUROTHERAPEUTICS ASENT
ST13
US500000075311634Class
42
Filing
75311634
Registration
2246600
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
12/30/2019
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
06/19/1997
Registration date
05/18/1999
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/30/2019
Last transaction
12/30/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
1997-01-00
First use in commerce
1997-01-00
Drawing code
1
Owner type
03
Owner location
Haddonfield, NJ
Examiner
STINE, DAVID
Law office
M50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
American Society for Experimental NeuroTherapeutics, The
American Society for Experimental NeuroTherapeutics, The
Representatives
THOMAS W BROOKE HOLLAND & KNIGHT LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
promoting public awareness of the need for development of safer and more effective pharmaceuticals for the treatment of neurologic diseases
Publications
History of USPTO decisions and trademark events.
27 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
12/30/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/30/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/30/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
11/13/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/18/2018
CORV
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY NOT ENTERED
09/19/2012
PAPER RECEIVED
09/13/2012
CFIT
CASE FILE IN TICRS
05/13/2011
CFIT
CASE FILE IN TICRS
04/15/2011
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/30/2009
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/30/2009
PLGL
ASSIGNED TO PARALEGAL
04/24/2009
E89R
TEAS SECTION 8 & 9 RECEIVED
04/22/2009
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/16/2004
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
07/02/2004
R.PR
REGISTERED-PRINCIPAL REGISTER
05/18/1999
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/24/1999
DOCK
ASSIGNED TO EXAMINER
02/17/1999
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/03/1999
IUAF
USE AMENDMENT FILED
12/30/1998
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
07/28/1998
PUBO
PUBLISHED FOR OPPOSITION
05/05/1998
NPUB
NOTICE OF PUBLICATION
04/03/1998
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/1998
CNEA
EXAMINER'S AMENDMENT MAILED
02/03/1998
DOCK
ASSIGNED TO EXAMINER
01/27/1998
Continuous trademark protection
Get notified about every new filing that threatens AMERICAN SOCIETY FOR EXPERIMENTAL NEUROTHERAPEUTICS ASENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.